Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Acq. announced
Director departure
Appointed director
CC transcript
|
|
X4 Pharmaceuticals, Inc (XFOR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/16/2023 |
SC 13G
| MILLENNIUM MANAGEMENT LLC reports a 5.2% stake in X4 PHARMACEUTICALS, INC. |
| 01/13/2023 |
SC 13G
| Empery Asset Management, LP reports a 5.1% stake in X4 Pharmaceuticals, Inc. |
| 01/19/2022 |
SC 13G
| Lincoln Park Capital Fund, LLC reports a 6.4% stake in X4 PHARMACEUTICALS, INC. |
| 11/17/2021 |
SC 13G
| Point72 Asset Management, L.P. reports a 5.6% stake in X4 Pharmaceuticals, Inc. |
| 02/02/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/30/2020 |
SC 13G
| Ikarian Capital, LLC reports a 5.1% stake in X4 PHARMACEUTICALS, INC. |
| 02/14/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/17/2019 |
SC 13G
| EcoR1 Capital, LLC reports a 7.2% stake in X4 Pharmaceuticals, Inc. |
| 12/09/2019 |
SC 13G
| Bain Capital Life Sciences Fund, L.P. has filed a Schedule 13D for X4 Pharmaceuticals, Inc. |
| 05/10/2019 |
SC 13G
| FMR LLC reports a 10.5% stake in X4 PHARMACEUTICALS INC |
| 04/23/2019 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P reports a 10% stake in X4 Pharmaceuticals, Inc. |
| 04/22/2019 |
SC 13G
| Cormorant Asset Management, LLC reports a 7.4% stake in X4 Pharmaceuticals, Inc. |
| 04/19/2019 |
SC 13G
| ORBIMED ADVISORS LLC reports a 9.8% stake in X4 PHARMACEUTICALS, INC. |
| 04/16/2019 |
SC 13G
| Flynn James E reports a 6.7% stake in X4 Pharmaceuticals, Inc. |
| 03/15/2019 |
SC 13G
| Bill & Melinda Gates Foundation reports a 1.8% stake in X4 Pharmaceuticals, Inc. |
| 02/13/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/11/2017 |
SC 13G
| FMR LLC reports a 10.8% stake in ARSANIS INC |
|
|